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A 7.5-year-old boy presented to a community clinic looking generally unwell. He was referred to our hospital 
and found to have end-stage kidney disease.  
He was born at 40 + 3 weeks gestation to non- consanguineous parents by normal vaginal delivery following 
spontaneous onset of labour after a maternal antepartum haemorrhage. His antenatal ultrasounds were normal at 
12, 20, 22, 30, 32 and 34 weeks. He was born in good condition, with a birth weight of 4 kg, and discharged on 
day 2 of life.  
From the time he was discharged home his mother was concerned about nystagmus, and at 8 weeks he was 
referred to the ophthalmologist as he was not fixing and following. He was reviewed by both a developmental 
paediatrician and an ophthalmologist on a monthly basis and was diagnosed with hypermetropia requiring 
glasses at 9 months of age. He had a cranial magnetic resonance imaging (MRI) scan at 11 months of age which 
was reported to be normal (Fig. 1).  
He was noted to have global developmental delay. Blood tests were taken at the age of 2 years as part of a 
genetics  
work-up, and these showed normal renal function (plasma creatinine 36 μmol/L, urea 3.5 mmol/L, sodium 141 
mmol/ L, potassium 4.5 mmol/L and haemoglobin 121 g/L). He did not walk independently until the age of 4.5 
years and was diagnosed with an autistic spectrum disorder at 7 years of age (only had four words at 9 years of 
age).  
He was diagnosed with pharyngitis and given oral antibi- otics by his general practitioner at the age of 7.5 years. 
A few weeks later he presented to a community clinic looking gen- erally unwell and was noted to be pale with 
a flow murmur. He was referred to hospital, and on admission his weight and height were 22.3 kg (>9th centile) 
and 117.1 cm (<9th centile), respectively, and he was hypertensive with systolic blood pressure of 155 mmHg. 
His urine protein:creatinine ratio was 124 mg/mmol, and his blood tests revealed a plasma  
creatinine level of 1262 μmol/L, urea 58 mmol/L, sodium 142 mmol/L, potassium 4.2 mmol/L, corrected 
calcium 1.56 mmol/L, phosphate 2.52 mmol/L, bicarbonate 6 mmol/ L and haemoglobin 55 g/L.  
Following admission and stabilisation, he was referred to a tertiary nephrology unit due to his deranged renal 
function, persistent hypocalcaemia and metabolic acidosis. A renal ul- trasound scan showed loss of 
corticomedullary differentiation and increased echogenicity, with his right kidney measuring 8.2 cm and left 
kidney measuring 9.2 cm (5th and 50th centiles for age are 7.4 cm and 8.8 cm, respectively).  
He then underwent a percutaneous renal biopsy under gen- eral anaesthetic, which contained 41 glomerular 
profiles of which five (12 %) were globally sclerosed. Two showed periglomerular fibrosis, and a number of the 
others showed mild ischaemic shrinkage. There was no mesangial thicken- ing, hypercellularity or segmental 
lesions. Glomerular base- ment membranes showed mild ischaemic shrinking on silver  
stain only, with negative Congo red staining for amyloid. There was focal tubular atrophy and diffuse interstitial 
oedema with a dense diffuse interstitial inflammatory infiltrate of lym- phocytes. In several foci lymphocytes 
were seen to infiltrate tubules and tubular rupture was noted. There were no specific glomerular deposits as 
revealed by immunocytochemistry (IgG, IgA, IgM or C3). Three sclerosed and one viable glo- merulus were 
visible upon electron microscopy examination, all of which showed some ischaemic shrinkage and foot pro- 
cess fusion but no deposits. The conclusion drawn from the biopsy results was acute tubulointerstitial nephritis 
(TIN), with the presence of sclerosis and atrophy consistent with a degree of chronicity (Fig. 2).  
The patient was commenced on corticosteroid therapy which he remained on for 4 months. Haemodialysis was 
started at presentation, and he has required this since. On referral to our quaternary paediatric nephrology 
service for transplant work-up at the age of 9 years, his history was reviewed and it was felt that he exhibited a 
number of features of Joubert syndrome (JS). His previous MRI scan was reviewed again and confirmed the 
pathognomic sign of JS. The results of his genetics work-up were sent, and further review also confirmed the 
diagnosis of JS.  
Questions  
1. What is the pathognomic sign of JS?  
2. What are the clinical features of JS?  
3. What are the renal manifestations typically seen in JS  
including the radiological and histological findings?  
4. What features of this boy’s biopsy was unusual for JS?  
 
